LncRNA HEM2ATM improves obesity-associated adipose tissues meta-inflammation and insulin resistance by interacting with heterogeneous nuclear ribonucleoprotein U

Copyright © 2023. Published by Elsevier Inc.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 247(2023) vom: 28. Feb., Seite 109234
Auteur principal: Xing, Yu-Jie (Auteur)
Autres auteurs: Zhang, Teng, Wan, Shu-Jun, Cheng, Yi, Zhou, Si-Min, Sun, Yue, Zhang, Hao-Ran, Yao, Xin-Ming, Hua, Qiang, Meng, Xiang-Jian, Zhang, Yan, Lv, Kun, Li, Chunxiao, Kong, Xiang
Format: Article en ligne
Langue:English
Publié: 2023
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Insulin resistance Long non-coding RNA Macrophages Obesity Heterogeneous-Nuclear Ribonucleoprotein U RNA, Long Noncoding Interleukin-6 Tumor Necrosis Factor-alpha
Description
Résumé:Copyright © 2023. Published by Elsevier Inc.
Obesity is a complicated metabolic disease characterized by meta-inflammation in adipose tissues. In this study, we explored the roles of a new long non-coding RNA (lncRNA), HEM2ATM, which is highly expressed in adipose tissue M2 macrophages, in modulating obesity-associated meta-inflammation and insulin resistance. HEM2ATM expression decreased significantly in adipose tissue macrophages (ATMs) obtained from epididymal adipose tissues of high-fat diet (HFD)-induced obese mice. Overexpression of macrophage HEM2ATM improved meta-inflammation and insulin resistance in the adipose tissues of HFD-fed mice. Functionally, HEM2ATM negatively regulated the production of pro-inflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in macrophages. Mechanistically, HEM2ATM bound to heterogeneous nuclear ribonucleoprotein U (hnRNP U), suppressed hnRNP U translocation from the nucleus to the cytoplasm, hindered the function of cytoplasmic hnRNP U on TNF-α and IL-6 mRNA stabilization, and decreased the secretion of TNF-α and IL-6. Collectively, HEM2ATM is a novel suppressor of obesity-associated meta-inflammation and insulin resistance
Description:Date Completed 14.02.2023
Date Revised 18.03.2023
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2023.109234